A new approach to the problems encountered with Opsite as a donor site dressing: systemic ethamsylate.
A prospective clinical trial has shown that systemic ethamsylate reduces the problems with exudation sometimes seen when Opsite is used as a dressing for split skin graft donor sites.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001557:Benzenesulfonates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004979:Ethamsylate / Q000008:administration & dosage / Q000627:therapeutic use*; D005122:Exudates and Transudates / Q000187:drug effects; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009779:Occlusive Dressings / Q000009:adverse effects*; D011140:Polyurethanes / Q000009:adverse effects*; D011446:Prospective Studies; D016038:Skin Transplantation; D014945:Wound Healing / Q000187:drug effects*
D001557:Benzenesulfonates; C027324:Opsiture; D011140:Polyurethanes; D004979:Ethamsylate